市场调查报告书
商品编码
1466526
药品包装市场:按类型、交付模式、包装水平、材料、最终用户 - 2024-2030 年全球预测Pharmaceutical Packaging Market by Type (Ampoules, Blister Packs, Caps & Closures), Delivery Mode (Injectables, IV Drugs, Nasal), Level of Packaging, Material, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年药品包装市场规模为1,568.7亿美元,预估2024年将达1,731.3亿美元,2030年将达3,070.5亿美元,复合年增长率为10.06%。
药品包装是指用于封装和保护药品的製程和材料。包括各种容器类型,如瓶子、管瓶、泡壳、管子、注射器、安瓿、封口、标籤和二次包装。包装旨在提供屏障保护、操作便利并传达有关药品的重要讯息。药品包装在确保药品的安全、品质和有效性方面发挥着重要作用。药品包装有多种应用,包括提供对环境因素和儿童防护的屏障保护,以及满足特定药物输送模式的要求。药品包装的主要最终使用者是药品製造商、医疗保健提供者和患者。药品包装市场的成长受到多种因素的影响,包括用于患者参与和识别的智慧包装的扩展、对初级药品包装的需求增加以及对生技药品包装的需求增加。此外,更严格的包装法规(例如儿童防护和防篡改)也正在推动创新和合规相关投资。然而,药品包装的扩张受到药品包装原材料价格变化、遵守全球和地区监管条件以及在保持包装完整性的同时实现永续性目标的阻碍。同时,药品包装市场的最新机会包括奈米技术的进步和创新的新一代包装解决方案、永续包装解决方案的出现、个性化治疗通讯协定定制的包装等。
主要市场统计 | |
---|---|
基准年[2023] | 1568.7亿美元 |
预测年份 [2024] | 1731.3亿美元 |
预测年份 [2030] | 3070.5亿美元 |
复合年增长率(%) | 10.06% |
类型 防潮和防污染增加了药品包装中泡壳包装的偏好
安瓿是小型密封玻璃或塑胶容器,用于封装药物样本并保护它们免受空气、污染和篡改。它们通常用于储存液体药品,非常适合一次性应用以保持无菌。泡壳包装是预成型的塑胶包装解决方案,可容纳锭剂和胶囊,并提供针对湿度和污染物等外部因素的屏障。由于给药方便、遵守用药而被广泛使用,从安全角度考虑,儿童用耐受性设计尤其受到青睐。盖子和封口是药品包装的重要组成部分,确保产品的完整性和安全性。它们的范围从简单的螺旋盖到复杂的儿童用防护和防篡改设计。药筒在给药中发挥重要作用,特别是在自行注射常见的情况下,例如糖尿病。药筒是多剂量管瓶的替代品,是使用笔式註射器时的首选。标籤和配件对于药品包装至关重要,可作为品牌和资讯载体以及防伪工具。配备用于追踪的 RFID 技术的智慧标籤和用于低温运输管理的温度敏感标籤越来越受欢迎。宝特瓶是从液体糖浆到锭剂等多种药品的常见包装型态。它的需求量很大,因为它重量轻且耐用。重要的是,製造商正在专注于生产可回收的塑胶瓶,以减少对环境的影响。袋子通常用于粉状和颗粒状药品,提供轻质且灵活的包装解决方案。它特别适合需要防潮和避光的产品。预填充吸入器为使用者提供即用剂量的药物,用于治疗气喘和慢性阻塞性肺病等疾病。预填充式注射器因其使用方便、剂量错误风险降低以及各种注射的高效输送而普及。管瓶是通常用于盛装液体药物的小瓶子。它对于多药物给药至关重要,并因其与多种药物的兼容性而受到重视。每种药品包装类型都满足市场的不同需求。安瓿和管瓶适用于无菌性很重要的肠胃外应用。注射器和吸入器等预填充选项优先考虑便利性和剂量准确性。瓶子和袋子适用于成药市场,在该市场中,运输和储存的便利性非常重要。泡壳包装和药筒由于其改善的患者依从性和易用性而变得越来越受欢迎。瓶盖、瓶盖、标籤和配件发挥整体支撑作用,注重产品安全并提供重要资讯。所有类别的最新趋势是转向永续材料和环保製造流程。
最终用户:药品製造中对维持产品完整性和延长保质期的需求不断增长
合约包装涉及委託给第三方服务提供者。当客户需要扩充性、上市速度和成本效率而无需投资内部包装设备时,他们更喜欢这个细分市场。成本节约、专业知识、最尖端科技和法规遵循是合约包装的关键驱动力。机构药局是指位于医院、诊所和疗养院等设施内的药局。这些设施需要有效的包装,以保持药物的完整性并促进高周转率患者照护环境中的药物依从性。我们专注于针对患者的单位剂量包装,以提高安全性、减少浪费并遵守严格的法规。药品製造部门包括从事药品和药物製造的公司。这些製造商优先考虑保护产品完整性、延长保质期并符合各个市场法规的包装。这强调客製化、阻隔性以及遵守 FDA 和 EMA 指南等国际标准。零售药局是药品和消费者之间最直接的接触点,需要包装能保护药品、影响消费者行为并展现品牌形象。消费者便利性、儿童、资讯展示和品牌塑造是零售药局的核心偏好。
区域洞察
受其先进的医疗基础设施、严格的法规结构和对药物输送解决方案的高需求的推动,美国已将自己定位为药品包装的领先国家。在投资和倡议方面,美国市场的生技药品领域正在显着成长,需要为敏感产品提供复杂的包装解决方案。该地区的公司继续申请创新包装设计和材料的专利。在南美洲,巴西和阿根廷等国家的医疗保健支出不断增加,医疗保健服务的普及正在推动药品包装的成长。欧盟国家的药品包装市场受到严格监管,并专注于病人安全和防伪措施。以病人为中心的设计和符合依从性的包装是全部区域消费者的主要需求。客户往往更喜欢整合安全功能并促进永续性的包装。欧盟的措施通常包括开发环保包装材料和回收计画。在中东富裕国家,对符合国际标准的高品质药品包装的需求不断增长。非洲有限的资源往往强调经济实惠且功能齐全的包装解决方案。然而,人们重新关注提高品质和打击假药。由于医疗保健产业的快速开拓、医疗支出的增加和老年人口的不断增加,亚太地区的新兴市场目前是全球成长最快的市场,特别是在中国、日本和澳洲等国家。中国政府促进医药创新的政策提高了客户对先进包装的期望。日本药品包装市场正在发展,注重精度、品质和产品完整性。人口老化正在增加消费者对易于使用且适合年龄的包装的需求。印度作为重要的学名药出口国,其药品包装市场具有成本效益的特性。
FPNV定位矩阵
FPNV定位矩阵对于评估药品包装市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对药品包装市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 医药包装市场的市场规模与预测是多少?
2.在医药包装市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3. 药品包装市场的技术趋势和法规结构是什么?
4.医药包装市场主要供应商的市场占有率为何?
5. 进入医药包装市场适合的型态和策略手段是什么?
[183 Pages Report] The Pharmaceutical Packaging Market size was estimated at USD 156.87 billion in 2023 and expected to reach USD 173.13 billion in 2024, at a CAGR 10.06% to reach USD 307.05 billion by 2030.
Pharmaceutical packaging refers to the processes and materials used to encase and protect pharmaceutical products. It includes a range of container types like bottles, vials, blisters, tubes, syringes, ampoules, closures, labels, and secondary packaging materials. The packaging is designed to provide barrier protection, convenience in handling, and convey essential information about the medications. Pharmaceutical packaging has a critical role in ensuring the safety, quality, and efficacy of drugs. It serves numerous applications, including providing barrier protection against environmental factors and child resistance and accommodating the demands of specific modes of drug delivery. The primary end-users of pharmaceutical packaging are pharmaceutical manufacturers, healthcare providers, and patients. Growth in the pharmaceutical packaging market is influenced by several factors, such as growing smart packaging for patient engagement and identification, rising demand for primary pharmaceutical packaging, and increasing demand for biologics packaging. Moreover, stricter regulations for packaging in terms of child resistance and tamper-evidence boost innovation and compliance-related investments. However, the expansion of pharmaceutical packaging is hindered by the price volatility of pharmaceutical packaging raw materials, adherence to the global and local regulatory landscape, and meeting sustainability goals while maintaining the integrity of the packaging. On the other hand, the latest opportunities within the pharmaceutical packaging market include the evolution of nanotechnology due to innovative and new-generation packaging solutions, the emergence of eco-friendly and sustainable packaging solutions, and the customization of packaging for personalized treatment protocols.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 156.87 billion |
Estimated Year [2024] | USD 173.13 billion |
Forecast Year [2030] | USD 307.05 billion |
CAGR (%) | 10.06% |
Type: Increasing preference for blister packs for pharmaceutical packaging due to resistance against humidity and contaminants
Ampoules are small sealed glass or plastic vessels that are used to contain and protect a sample of a pharmaceutical from air, contamination, or tampering. They are typically used to store pharmaceuticals in liquid form and are ideal for single-use applications, maintaining sterility. Blister packs are pre-formed plastic packaging solutions that accommodate tablets or capsules, providing a barrier against external factors such as humidity and contaminants. They are extensively used due to their convenience for dose administration and adherence, with child-resistant designs being particularly preferred for safety purposes. Caps and closures are critical components of pharmaceutical packaging, providing the integrity and safety of the product. They range from simple screw caps to complex child-resistant and tamper-evident designs. Cartridges serve a purpose in the administration of drugs, especially for conditions like diabetes, where self-injection is common. They offer an alternative to vials for multi-dose applications and are preferred when using pen injectors. Labels and accessories are indispensable for pharmaceutical packaging, serving as branding and informational mediums and as anti-counterfeiting tools. Smart labels with RFID technology for tracking and temperature-sensitive labels for cold chain management are gaining traction. Plastic bottles are a common packaging choice for a wide range of pharmaceutical products, from liquid syrups to tablets. Demand for these is high due to their lightweight nature and durability. Importantly, manufacturers are now concentrating on producing recyclable plastic bottles to reduce environmental impact. Pouches, often used for powdered or granulated pharmaceutical products, offer lightweight and flexible packaging solutions. They are especially preferred for products that require protection from moisture and light. Pre-filled inhalers provide users with ready-to-administer doses of medication for conditions such as asthma and chronic obstructive pulmonary disease. Pre-filled syringes have become popular due to their ease of use, reduced risk of dosing errors, and efficient delivery of various injectables. Vials are small bottles typically used for holding liquid medications. They are essential for multi-dose applications and are prized for their compatibility with multiple drug types. Each pharmaceutical packaging type caters to different needs within the market. Ampoules and vials favor parenteral applications with an emphasis on sterility. Pre-filled options, such as syringes and inhalers, prioritize convenience and dose accuracy. Bottles and pouches are geared towards the over-the-counter market, where ease of transport and storage are key. Blister packs and cartridges are increasingly preferred for their patient adherence and ease of use features. Caps, closures, labels, and accessories play supporting roles across the board, focusing on securing the product and providing vital information. The recent trend across all categories is the shift towards sustainable materials and environmentally-friendly manufacturing processes.
End User: Rising demand in pharmaceutical manufacturing for maintaining product integrity and extending shelf life
Contract packaging, or pharma co-packing, involves outsourcing pharmaceutical packaging to a third-party service provider. Clients prefer this segment when they require scalability, speed to market, and cost-efficiency without investing in in-house packaging facilities. Cost savings, expertise, state-of-the-art technology, and regulatory compliance are the primary driving factors for contract packaging. Institutional pharmacy refers to pharmacies within institutions like hospitals, clinics, and nursing homes. These entities require efficient packaging that maintains medication integrity and promotes adherence in high-turnover patient care settings. Emphasis is on patient-specific, unit-dose packaging, which enhances safety, reduces waste, and complies with stringent regulations. The Pharmaceutical manufacturing segment encompasses companies involved in the production of drugs and medications. These manufacturers prioritize packaging that protects product integrity, extends shelf life, and complies with regulations across various markets. This focuses on customization, barrier properties, and compliance with international standards such as FDA and EMA guidelines. Retail pharmacy is the most direct interface between medications and consumers, with packaging that safeguards the medication, influences consumer behaviors, and presents brand identity. Consumer convenience, child-resistant features, informational labeling, and branding are the core preferences for retail pharmacies.
Regional Insights
The United States stands as a prominent country for pharmaceutical packaging, driven by advanced healthcare infrastructure, stringent regulatory frameworks, and a high demand for drug delivery solutions. Regarding investments and initiatives, the US market is witnessing substantial growth in the biologics sector, necessitating sophisticated packaging solutions for sensitive products. Companies in the region continuously file patents for groundbreaking packaging designs and materials. In South America, rising healthcare expenditures and increasing access to healthcare services in countries such as Brazil and Argentina facilitate the growth of pharmaceutical packaging. The pharmaceutical packaging market in EU countries is highly regulated, focusing on patient safety and anti-counterfeiting measures. Patient-centric designs and adherence-compliant packaging are primary consumer needs across this region. Customers tend to favor packaging that integrates security features and promotes sustainability. EU initiatives often involve developing eco-friendly packaging materials and recycling programs. In wealthier nations within the Middle East, there is an increasing demand for high-quality pharmaceutical packaging that aligns with international standards. Africa, being a resource-limited setting, tends to focus on affordable and functional packaging solutions. However, there is an emerging focus on improving quality and counteracting counterfeit medications. The pharmaceutical packaging market in the APAC region is currently the fastest-growing globally due to rapidly developing healthcare sectors, increased healthcare spending, and a growing elderly population, especially in countries such as China, Japan, and Australia. The Chinese government's policies promoting innovation in pharmaceuticals have increased customer expectations for advanced packaging. Japan's pharmaceutical packaging market is developed, emphasizing precision, quality, and product integrity. The aging population leads to a consumer need for easy-to-use and senior-friendly packaging. India's pharmaceutical packaging market is characterized by cost-effectiveness due to the country's role as a significant exporter of generic drugs.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Packaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Packaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Packaging Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor PLC, AptarGroup, Inc., Becton, Dickinson and Company, Berry Global, Inc., Catalent, Inc., CCL Industries Inc., Comar, LLC, Constantia Flexibles, Drug Plastics Group, EPL Limited, Gaplast GmbH, Gerresheimer AG, Klockner Pentaplast Group, Lonza Group AG, McKesson Corporation, Mondi PLC, Nipro Corporation, Nolato AB, Origin Pharma Packaging, Schott AG, Sealed Air Corporation, SGD S.A., URSATEC GmbH, Vetter Pharma-Fertigung GmbH & Co. KG, W. L. Gore & Associates Inc., West Pharmaceutical Services, Inc., and Westrock Company by Smurfit Kappa Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pharmaceutical Packaging Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Packaging Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Packaging Market?
4. What is the market share of the leading vendors in the Pharmaceutical Packaging Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Packaging Market?